Analyses / Procedural Viability Check / 119 · HR 2715 Procedural Viability Check

119-HR-2715 DC Insider Procedural Viability Check

119 · HR 2715 Destruction of Hazardous Imports Act

Procedural read

Bipartisan, low-cost FDA import‑safety tweak with real momentum: H.R. 2715 cleared House Energy & Commerce 43–0 on May 21, 2026; a Senate companion (S.3213) sits in HELP; with unified GOP control and clear vehicles (Ag‑FDA appropriations or hotline/UC), the bill is well‑positioned but still faces potential Senate holds and calendar compression. Composite: 4/5. [1]docs.house.gov — E&C Full Committee Vote 013 (May 21, 2026): H.R. 2715 — 43–0

4/5
Composite viability
43yeas
E&C committee vote
Published
29 May 2026
Updated
29 May 2026
Tags
procedural-viability · E&C · FDA
Unvetted
01 · Section

Procedural viability: H.R. 2715 (119th) — Destruction of Hazardous Imports Act

Chamber of origin: House; bipartisan lead sponsors Rep. Clay Higgins (R‑LA) and Rep. Troy Carter (D‑LA). Text amends FDCA §801(a) to allow destruction of any refused article that presents a significant public‑health concern and creates a related prohibited act. House Energy & Commerce reported the bill 43–0 on May 21, 2026, after a May 13 Health Subcommittee markup; a Senate companion (S.3213) is parked in HELP. GOP controls both chambers (Senate majority led by Thune), and the White House (Trump/Vance). [2]GPO via Congress.gov — H.R. 2715 (GPO bill text, introduced)

  • Chamber of Origin — High: House start, bipartisan (R–D Louisiana) lead; strong signal vote in E&C (43–0). [2]GPO via Congress.gov — H.R. 2715 (GPO bill text, introduced)
  • Vehicle Type — Medium‑High: Narrow authorizing change; can ride Ag‑FDA appropriations if floor time tight. [3]House Appropriations (Republicans) — House Appropriations (Ag‑FDA) — jurisdicti…
  • Senate Threshold — Medium: Not reconciliation‑eligible; absent UC, needs 60. GOP majority + low controversy improves hotline/UC odds, but a single hold can slow it. [4]U.S. Senate — Complete list of Senate majority/minority leaders (shows Thune as…
  • Committee Path — High: Productive path so far (Health Subcmte → Full E&C, 43–0). Senate HELP chaired by Cassidy (R‑LA) is a friendly venue for FDA tools. [5]docs.house.gov — Health Subcommittee markup notice (May 13, 2026) — H.R. 2715 i…
  • Must‑Pass Potential — High: Natural hitch to Agriculture–FDA appropriations if needed; also viable for a bipartisan mini‑package. [3]House Appropriations (Republicans) — House Appropriations (Ag‑FDA) — jurisdicti…
  • Budget Scorekeeping — High: No posted CBO score; scope suggests minimal PAYGO friction (process authority, not new spending). [6]Congress.gov — H.R. 2715 — Congress.gov overview (CBO: 0 posted)
  • Calendar Math — Medium‑High: House and Senate in session through June/July; August recess compresses windows, with a fall CR/omnibus as a backup vehicle. [7]Office of the House Majority Leader — House 2026 calendar (updated Mar. 26)

Context: Current law already lets FDA administratively destroy certain refused low‑value drugs/devices under FDASIA and the 2015 final rule; H.R. 2715 broadens that authority to any refused article posing a significant public‑health concern and criminalizes unauthorized movement post‑destruction decision. Support letters from seafood/public‑health coalitions and FDA request language for 2026 strengthen the record. [8]FDA — FDA summary — Administrative Destruction of Certain Drugs Refused Admissi…

  • Expected path and timing (operative view): - House: Suspension or structured rule in June/July is plausible given 43–0 committee vote. [1]docs.house.gov — E&C Full Committee Vote 013 (May 21, 2026): H.R. 2715 — 43–0 - Senate: HELP can mark and hotline; clean bill could clear by UC if holds lift; otherwise 60‑vote path likely still attainable. [10]Senate HELP Committee (senate.gov) — Cassidy seated as HELP Chair for the 119t… - Fallback: Ride the FY27 Ag‑FDA bill or a fall CR/mini‑bus if standalone time evaporates. [3]House Appropriations (Republicans) — House Appropriations (Ag‑FDA) — jurisdicti…
Composite viability
4/5
E&C committee vote
43yeas
Sources cited
  1. [1] E&C Full Committee Vote 013 (May 21, 2026): H.R. 2715 — 43–0 docs.house.gov
  2. [2] H.R. 2715 (GPO bill text, introduced) GPO via Congress.gov
  3. [3] House Appropriations (Ag‑FDA) — jurisdiction and FY25 press release House Appropriations (Republicans)
  4. [4] Complete list of Senate majority/minority leaders (shows Thune as Majority Leader, 119th) U.S. Senate
  5. [5] Health Subcommittee markup notice (May 13, 2026) — H.R. 2715 included docs.house.gov
  6. [6] H.R. 2715 — Congress.gov overview (CBO: 0 posted) Congress.gov
  7. [7] House 2026 calendar (updated Mar. 26) Office of the House Majority Leader
  8. [8] FDA summary — Administrative Destruction of Certain Drugs Refused Admission (80 FR 55237, 2015) FDA
  9. [9] govinfo.gov
  10. [10] Cassidy seated as HELP Chair for the 119th Congress Senate HELP Committee (senate.gov)

Discussion